Document is current
Any future updates will be listed below
-
Authors
Rotbei, Sayna
Soler, Pablo Matías
Merino-Barbancho, Beatriz
Lopez-Perez, Laura
Anchuelo, Arturo Corbatón
García, Luis Picazo
Forés, Ricardo Mesanza
Matus, Laura Mariel
Albert, Ricardo Muñoz
Andicoechea, Aitor Odiaga
Panadero, Raquel Piñero
San Martín Díez, María Ángeles
Sánchez, Ainhoa Burzaco
Barrón, Rosana Soriano
Irimia, Andrea
Esculano, Esther Ruescas
Vinceixo, Mireia Cramp
Chaib, F. Beddar
Tourab, Hania
Fico, Giuseppe
Botta, Alessio
-
Funding
Funding for this research was provided by:
Karolinska Institute
- License Information
-
More Information
Article History
Received: 20 October 2025
Accepted: 27 February 2026
First Online: 14 March 2026
Declarations
:
: This study was reviewed and approved by the Comité de Ética de la Investigación con medicamentos (CEIm) del Hospital Clínico San Carlos (Madrid, Spain) [Approval code: 19/332-E]. The Committee determined that the requirement for informed consent was waived, as the study was retrospective in nature and involved the review of existing medical records. All procedures were conducted in accordance with the ethical standards of the institutional research committee and with the Declaration of Helsinki and its later amendments, as well as applicable national regulations.
: Not applicable.
: The authors declare no conflict of interest.
